Discover how the Inflation Reduction Act benefits Medicare Part D by reducing prescription costs and improving health outcomes for beneficiaries.

Explore the impact of Pharmacy Benefit Managers on insurance premiums and drug pricing, and the regulatory insights from Abby Alpert's recent study.

Eli Lilly's latest announcement on Medicare drug plans highlights the $50 cap on expenses for weight-loss medications. Learn more about the implications.

Explore recent legislative changes impacting Ambulatory Surgical Centers, focusing on noncompete agreements, healthcare compliance, and Medicare coverage enhancements.

Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.

Explore the new Ambulatory Specialty Model by CMS, focusing on value-based reimbursement for cardiologists in heart failure care. Learn its implications and requirements.

Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.

Explore the intricacies of Medicare, vital for retirement planning. Understand enrollment periods, benefits, and essential coverage options for optimal decision-making.

Discover how telehealth for Medicare beneficiaries has evolved, with 60 million appointments in 2023, ensuring healthcare access for older adults.

Explore how rising prescription drug costs affect Medicare beneficiaries and learn about the Extra Help program for affordable medications.